From May 1980 to November 1981, 51 consecutive patients with locally advanced, recurrent or metastatic head and neck squamous carcinoma were treated with 2 successive outpatient chemotherapeutic regimens including adriamycin, cyclophosphamide, vincristine, bleomycin, methotrexate and 5-fluorouracil with or without mitomycin-C. A 34% objective response rate was obtained with acceptable toxicity and good patient compliance. The presence of mitomycin-C did not influence response rate. Median survival was 9 months.
Get full access to this article
View all access options for this article.
References
1.
AmerM.H., IzbickiR.M., VaitkeviciusV.K., Al-SarrafM.: Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer - Phase II.Cancer, 45: 217–223, 1980.
2.
De ContiR., SchoenfeldD.: A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer.Cancer, 48: 1061–1072, 1981.
3.
ErvinT.J., WeichselbaumR., MillerB., MeshadM., PosnerM., FabianR.: Treatment of advanced squamous cell carcinoma of head and neck with cisplatin, bleomycin, and methotrexate (PBM).Cancer Treat. Rep., 65: 787–791, 1981.
4.
GlickJ.H., TaylorS.G.: Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: A review.Int. J. Radiat. Oncol. Biol. Phys., 7: 229–242, 1981.
5.
HongW.K., SchaeferS., IsselB., CummingsC., LuedkeD., BromerR., LavinL.: A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinomas of the head and neck.ASCO Proceedings, C787, 1982.
6.
IsraëlL., AguileraJ., SoudantT., PenotJ.C., BreauJ.L.: Head and neck cancer: 57 patients treated with cis-platinum and continuous bleomycin; 53 patients treated with cis-platinum, mitomycin-C, and continuous blemycin.ASCO Proceedings, C779, 1982.
7.
KaplanB.H., VoglS.E., ChiutenD., LanhamR., WollnerD.: Chemotherapy of advanced cancer of the head and neck (HNCa) with methotrexate (M), bleomycin (B), and cis-diamminedichloroplatinum (D) in combination - « MBD ».ASCO Proceedings, C836, 1979.
8.
KaplanB.H., VoglS.E., LernerH.: Head and neck cancer (HNCa) chemotherapy with diamminedichloroplatinum (D), bleomycin (B), methotrexate (M) and Mitomycin (Mito) - « Mito-MDB ».ASCO Proceedings, C629, 1980.
9.
KischJ., DrelichmanA., JacobsJ., HoschnerJ., KinzieJ., LohJ., WeaverA., Al-SarrafM.: Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.Cancer Treat. Rep., 66: 471–474, 1982.
10.
MolinariR., MattavelliF., CantùG., ChiesaF., CostaL., TanciniG.: Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (VBM) based on cell kinetics in the palliative treatment of head and neck squamous carcinoma.Eur. J. Cancer, 16: 469–472, 1980.
11.
PerryD.J., DavisR.K., WeissR.B.: Combined modality treatment with combination chemotherapy for advanced squamous cell carcinoma of the head and neck.ASCO Proceedings, C749, 1982.
12.
PriceL.A., HillD.T.: Kinetically based combination chemotherapy for head and neck cancer: Implications for improved survival.ASCO Proceedings, C602, 1980.
13.
PriceL.A., HillD.T., CalvertA.H., ShawH.J., HughesK.B.: Kinetically-based multiple drug treatment for advanced head and neck cancer.Br. Med. J., 3: 10–11, 1975.
14.
RaafatJ., OsterM.W.: Combination chemotherapy for advanced squamous carcinoma of the head and neck.Cancer Treat. Rep., 64: 187–190, 1980.
15.
SpauldingM.B., De Los SantosR., SananiS., CantyR., SundquistN.: Infusion 5-FU/Velban.A non-toxic combination active in head and neck cancer. ASCO Proceedings, C772, 1982.
16.
TannockI., SutherlandD., OsobaD.: Failure of short-course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancer.Cancer, 49: 1358–1361, 1982.
17.
TNM Classification of Malignant Tumours.Geneva: International Union Against Cancer (UICC), 3rd Ed., Genève, 1978.
18.
TrovòM.G., RoncadinM., De PaoliA., TirelliU., VeronesiA., GalligioniE., TumoloS., GrigolettoE.: Sequential polychemotherapy with vincristine, bleomycin and methotrexate in the treatment of advanced head and neck malignancies.Chemioter. Oncol., 2: 132–135, 1979.
19.
VeronesiA., BarzanL., MagriM.D., TirelliU., GalligioniE., TrovòM.G., TumoloS., ComorettoR., GrigolettoE.: Sequential combination chemotherapy of advanced head and neck carcinoma.Re-evaluation of a highly effective regimen. Strahlenther., 157: 277–279, 1981.
20.
WilliamsS.D., EinhornL.H., Velez-GarciaE., EssesseeI., RatkinG., BirchR., GarrardJ.: Chemotherapy of head and neck cancer: Comparison of cisplatin+vinblastine+bleomycin (PVB) versus methotrexate (MTX).ASCO Proceedings, C784, 1982.
